Pharmacy and Poisons Board of Hong Kong has issued 5 New Guidances for Advanced Therapy Products
In June 2021, The Pharmacy and Poisons Board of Hong Kong issued 5 new guidances for Advanced Therapy Products. These guidances will be effective in August …
ACCSQ-PPWG Endorsed 3 Manuals in Connection with ASEAN Mutual Recognition Arrangement for Bioequivalence Study Reports of Generic Medicinal Products
An ASEAN Mutual Recognition Arrangement (MRA) for Bioequivalence (BE) Study Reports of Generic Medicinal Products was signed on 2nd November 2017 in …
HSA Singapore issues new guidance on Consent Requirements for Clinical Trials Involving Collection and Use of Human Tissue
On 1st July 2021 , Health Sciences Authority (HSA) Singapore issued new guidance on Consent Requirements for Clinical Trials Involving Collection and Use of Human Tissue, which will applies …
Access Consortium Releases Strategic Plan for 2021 – 2024
Access Consortium has released their Strategic Plan 2021-2024 in June 2021 to allow shareholders to learn more about the future …
Singapore HSA Publishes Regulatory Guideline for 3D-Printed Medical Devices
On 15th July 2021, HSA has finalised the Regulatory Guideline for 3D-printed medical devices. A separate FAQ has been compiled …
ASEAN Revises the ASEAN Variation Guidelines and Issued The Q&A on ASEAN Stability Guidelines
The ASEAN ACCSQ-PPWG has endorsed the following documents. (i) the ASEAN Variation Guideline (AVG) Rev. 2; endorsed at the 31st …
Hong Kong DOH Updates List of Recognised Standards for Medical Devices
In May 2021, Hong Kong Department of Health updated the RS-01: List of Recognised Standards for Medical Devices Medical devices …
Hong Kong DOH Updates Guidances for Listing of General Medical Devices and IVDs
In April 2021, Hong Kong Department of Health updated the guidances for listing of Class II/III/IV General Medical Devices and Class B, C and D In Vitro Diagnostic …
Hong Kong DOH Revised Submission Timeframes for Medical Device Adverse Event Reports
In April 2021, Hong Kong Department of Health updated the GN-03, Guidance Notes for Adverse Event Reporting by Local Responsible Persons. …